ArticleJournal of experimental & clinical cancer research : CR2019

A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.

Meifang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.